PortalPublikationenOutcome of Surgeon-Modified Fenestrated/Branched Stent-Graft...

Outcome of Surgeon-Modified Fenestrated/Branched Stent-Grafts for Symptomatic Complex Aortic Pathologies or Contained Rupture

Standard

Outcome of Surgeon-Modified Fenestrated/Branched Stent-Grafts for Symptomatic Complex Aortic Pathologies or Contained Rupture. / Tsilimparis, Nikolaos; Heidemann, Franziska; Rohlffs, Fiona; Diener, Holger; Wipper, Sabine; Debus, E Sebastian; Kölbel, Tilo.

in: J ENDOVASC THER, Jahrgang 24, Nr. 6, 12.2017, S. 825-832.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Tsilimparis, N, Heidemann, F, Rohlffs, F, Diener, H, Wipper, S, Debus, ES & Kölbel, T 2017, 'Outcome of Surgeon-Modified Fenestrated/Branched Stent-Grafts for Symptomatic Complex Aortic Pathologies or Contained Rupture', J ENDOVASC THER, Jg. 24, Nr. 6, S. 825-832. https://doi.org/10.1177/1526602817729673

APA

Tsilimparis, N., Heidemann, F., Rohlffs, F., Diener, H., Wipper, S., Debus, E. S., & Kölbel, T. (2017). Outcome of Surgeon-Modified Fenestrated/Branched Stent-Grafts for Symptomatic Complex Aortic Pathologies or Contained Rupture. J ENDOVASC THER, 24(6), 825-832. https://doi.org/10.1177/1526602817729673

Vancouver

Tsilimparis N, Heidemann F, Rohlffs F, Diener H, Wipper S, Debus ES et al. Outcome of Surgeon-Modified Fenestrated/Branched Stent-Grafts for Symptomatic Complex Aortic Pathologies or Contained Rupture. J ENDOVASC THER. 2017 Dez;24(6):825-832. https://doi.org/10.1177/1526602817729673

Bibtex

@article{090281be4618442da9bf6e5531288066,
title = "Outcome of Surgeon-Modified Fenestrated/Branched Stent-Grafts for Symptomatic Complex Aortic Pathologies or Contained Rupture",
abstract = "PURPOSE: To analyze the outcome of surgeon-modified fenestrated and branched stent-grafts (sm-FBSG) in high-risk patients with symptomatic complex aortic pathology or contained rupture.METHODS: A single-center retrospective analysis was conducted of 21 consecutive patients (mean age 70 years, range 58-87; 16 men) treated with a sm-FBSG from April 2014 to September 2016. The indications included 11 thoracoabdominal and 10 pararenal aortic pathologies, which presented as symptomatic in 8 and as contained rupture in 13 patients. The mean aneurysm diameter was 7.4±2.3 cm.RESULTS: Technical success was 100%. From 1 to 4 (mean 3) renovisceral branch vessels were targeted with fenestrations. The mean length of in-hospital stay was 19 days (range 1-78). There was 1 death within 30 days and 2 further in-hospital deaths. Two patients suffered permanent spinal cord injury, 2 developed respiratory failure, and 2 had renal failure requiring temporary or permanent dialysis. No myocardial infarction, stroke, or bowel ischemia occurred. Six early endoleaks (3 type II and 3 minor type III) were detected. Mean follow-up was 11.2 months (range 2-33) in 17 patients. One late aneurysm-related death occurred. All 13 follow-up imaging studies showed patent target renovisceral vessels, with 1 type I and 2 type II endoleaks.CONCLUSION: Sm-FBSG can be utilized for urgent treatment of complex abdominal and thoracoabdominal aortic pathologies in high-risk patients with anatomy unsuitable for commercially available stent-grafts.",
keywords = "Aged, Aged, 80 and over, Aortic Aneurysm, Abdominal/surgery, Blood Vessel Prosthesis, Blood Vessel Prosthesis Implantation, Endovascular Procedures, Humans, Male, Middle Aged, Postoperative Complications, Prosthesis Design, Retrospective Studies, Stents, Surgeons, Time Factors, Treatment Outcome",
author = "Nikolaos Tsilimparis and Franziska Heidemann and Fiona Rohlffs and Holger Diener and Sabine Wipper and Debus, {E Sebastian} and Tilo K{\"o}lbel",
year = "2017",
month = dec,
doi = "10.1177/1526602817729673",
language = "English",
volume = "24",
pages = "825--832",
journal = "J ENDOVASC THER",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "6",

}

RIS

TY - JOUR

T1 - Outcome of Surgeon-Modified Fenestrated/Branched Stent-Grafts for Symptomatic Complex Aortic Pathologies or Contained Rupture

AU - Tsilimparis, Nikolaos

AU - Heidemann, Franziska

AU - Rohlffs, Fiona

AU - Diener, Holger

AU - Wipper, Sabine

AU - Debus, E Sebastian

AU - Kölbel, Tilo

PY - 2017/12

Y1 - 2017/12

N2 - PURPOSE: To analyze the outcome of surgeon-modified fenestrated and branched stent-grafts (sm-FBSG) in high-risk patients with symptomatic complex aortic pathology or contained rupture.METHODS: A single-center retrospective analysis was conducted of 21 consecutive patients (mean age 70 years, range 58-87; 16 men) treated with a sm-FBSG from April 2014 to September 2016. The indications included 11 thoracoabdominal and 10 pararenal aortic pathologies, which presented as symptomatic in 8 and as contained rupture in 13 patients. The mean aneurysm diameter was 7.4±2.3 cm.RESULTS: Technical success was 100%. From 1 to 4 (mean 3) renovisceral branch vessels were targeted with fenestrations. The mean length of in-hospital stay was 19 days (range 1-78). There was 1 death within 30 days and 2 further in-hospital deaths. Two patients suffered permanent spinal cord injury, 2 developed respiratory failure, and 2 had renal failure requiring temporary or permanent dialysis. No myocardial infarction, stroke, or bowel ischemia occurred. Six early endoleaks (3 type II and 3 minor type III) were detected. Mean follow-up was 11.2 months (range 2-33) in 17 patients. One late aneurysm-related death occurred. All 13 follow-up imaging studies showed patent target renovisceral vessels, with 1 type I and 2 type II endoleaks.CONCLUSION: Sm-FBSG can be utilized for urgent treatment of complex abdominal and thoracoabdominal aortic pathologies in high-risk patients with anatomy unsuitable for commercially available stent-grafts.

AB - PURPOSE: To analyze the outcome of surgeon-modified fenestrated and branched stent-grafts (sm-FBSG) in high-risk patients with symptomatic complex aortic pathology or contained rupture.METHODS: A single-center retrospective analysis was conducted of 21 consecutive patients (mean age 70 years, range 58-87; 16 men) treated with a sm-FBSG from April 2014 to September 2016. The indications included 11 thoracoabdominal and 10 pararenal aortic pathologies, which presented as symptomatic in 8 and as contained rupture in 13 patients. The mean aneurysm diameter was 7.4±2.3 cm.RESULTS: Technical success was 100%. From 1 to 4 (mean 3) renovisceral branch vessels were targeted with fenestrations. The mean length of in-hospital stay was 19 days (range 1-78). There was 1 death within 30 days and 2 further in-hospital deaths. Two patients suffered permanent spinal cord injury, 2 developed respiratory failure, and 2 had renal failure requiring temporary or permanent dialysis. No myocardial infarction, stroke, or bowel ischemia occurred. Six early endoleaks (3 type II and 3 minor type III) were detected. Mean follow-up was 11.2 months (range 2-33) in 17 patients. One late aneurysm-related death occurred. All 13 follow-up imaging studies showed patent target renovisceral vessels, with 1 type I and 2 type II endoleaks.CONCLUSION: Sm-FBSG can be utilized for urgent treatment of complex abdominal and thoracoabdominal aortic pathologies in high-risk patients with anatomy unsuitable for commercially available stent-grafts.

KW - Aged

KW - Aged, 80 and over

KW - Aortic Aneurysm, Abdominal/surgery

KW - Blood Vessel Prosthesis

KW - Blood Vessel Prosthesis Implantation

KW - Endovascular Procedures

KW - Humans

KW - Male

KW - Middle Aged

KW - Postoperative Complications

KW - Prosthesis Design

KW - Retrospective Studies

KW - Stents

KW - Surgeons

KW - Time Factors

KW - Treatment Outcome

U2 - 10.1177/1526602817729673

DO - 10.1177/1526602817729673

M3 - SCORING: Journal article

C2 - 28874089

VL - 24

SP - 825

EP - 832

JO - J ENDOVASC THER

JF - J ENDOVASC THER

SN - 1526-6028

IS - 6

ER -